Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA159705 ID: 159705

Vascular histone deacetylation by pharmacological HDAC inhibition

This SuperSeries is composed of the SubSeries listed below. HDAC inhibitors are thought to regulate gene expression by post-translational modification of histone as well as non-histone proteins. Often studied at single loci, increased histone acetylation is the paradigmatic mechanism of action, however, little is known of the extent of genome-wide changes of the mammalian genome when stimulated by the hydroxamic acids, TSA and SAHA. In primary human vascular endothelial cells we map the chromatin modifications, histone H3 acetylation of lysine 9 and 14 (H3K9/14ac) using chromatin immunoprecipitation (ChIP) coupled with massive parallel sequencing (ChIP-seq). Since acetylation mediated gene expression is often associated with modification of other lysine residues we also examined H3K4me3 and H3K9me3 as well as changes in CpG methylation (CpG-seq). More...
AccessionPRJNA159705; GEO: GSE37378
TypeUmbrella project
Publications
  • Rafehi H et al., "HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs.", Noncoding RNA, 2016 May 25;2(2)
  • Rafehi H et al., "Vascular histone deacetylation by pharmacological HDAC inhibition.", Genome Res, 2014 Aug;24(8):1271-84
SubmissionRegistration date: 18-Apr-2012
Human Epigenetics, Diabetes, Monash University Central Clinical School
RelevanceSuperseries
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments65
Publications
PubMed3
PMC3
Other datasets
BioSample65
GEO DataSets7
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes21
SRA Data Details
ParameterValue
Data volume, Gbases60
Data volume, Mbytes35395
Vascular histone deacetylation by pharmacological HDAC inhibition encompasses the following 6 sub-projects:
Project TypeNumber of Projects
Epigenomics4
BioProject
accession
OrganismTitle
PRJNA159809Homo sapiensVascular histone deacetylation by pharmacological HDAC inhibition [TSA, ChIP-seq] (Human Epigenetics, Diabetes,...)
PRJNA238014Homo sapiensVascular histone deacetylation by pharmacological HDAC inhibition [TSA, MBD-seq] (Human Epigenetics, Diabetes,...)
PRJNA238015Homo sapiensVascular histone deacetylation by pharmacological HDAC inhibition [SAHA, ChIP-seq] (Human Epigenetics, Diabetes,...)
PRJNA238016Mus musculusVascular histone deacetylation by pharmacological HDAC inhibition [TSA, mouse, ChIP-seq] (Human Epigenetics, Diabetes,...)
Transcriptome or Gene expression2
BioProject
accession
OrganismTitle
PRJNA159807Homo sapiensVascular histone deacetylation by pharmacological HDAC inhibition [TSA, RNA-seq] (Human Epigenetics, Diabetes,...)
PRJNA238012Homo sapiensVascular histone deacetylation by pharmacological HDAC inhibition [SAHA, RNA-seq] (Human Epigenetics, Diabetes,...)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center